Structure Therapeutics Inc (GPCR)
41.92
+3.17
(+8.18%)
USD |
NASDAQ |
Sep 20, 16:00
41.85
-0.07
(-0.17%)
After-Hours: 20:00
Structure Therapeutics Total Liabilities (Quarterly): 26.00M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 26.00M |
| March 31, 2024 | 27.41M |
| December 31, 2023 | 29.05M |
| September 30, 2023 | 23.41M |
| June 30, 2023 | 15.01M |
| Date | Value |
|---|---|
| March 31, 2023 | 11.00M |
| December 31, 2022 | 212.98M |
| September 30, 2022 | 212.32M |
| December 31, 2021 | 175.89M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
11.00M
Minimum
Mar 2023
212.98M
Maximum
Dec 2022
81.45M
Average
27.41M
Median
Mar 2024
Total Liabilities (Quarterly) Benchmarks
| Viking Therapeutics Inc | 25.86M |
| Eli Lilly and Co | 58.24B |
| Amgen Inc | 84.98B |
| Pfizer Inc | 128.22B |
| Novo Nordisk AS | 36.87B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 947.03M |
| Shareholders Equity (Quarterly) | 921.03M |